openPR Logo
Press release

Central Nervous System (CNS) Therapeutics Market to Reach USD 152.4 Billion by 2034

11-17-2025 02:41 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Central Nervous System (CNS) Therapeutics Market

Central Nervous System (CNS) Therapeutics Market

Pune, India, November 2025 - The global Central Nervous System (CNS) Therapeutics Market is set for strong expansion, projected to grow from USD 93.7 billion in 2024 to USD 152.4 billion by 2034, registering a CAGR of 4.9%, according to the latest report by Exactitude Consultancy. Growth is primarily driven by increasing cases of neurological disorders, wider adoption of biologics, and rapid progress in CNS-targeted therapeutics.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/51211

Key Takeaways
• Market Size (2024): USD 93.7 Billion
• Forecast (2034): USD 152.4 Billion
• CAGR: 4.9% (2024-2034)
• Top Segments: Neurodegenerative diseases, psychiatric disorders, pain management
• Top Players: Biogen, Pfizer, Novartis, Eli Lilly, Roche, Teva, Johnson & Johnson
• Key Trend: Shift toward precision neurology & CNS biologics

Market Story
Neurological conditions-including Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, migraine, and depression-continue to represent a growing global healthcare burden. Rising geriatric population, increased awareness, and improved diagnostic capabilities have significantly expanded demand for CNS therapeutics.

Innovations in targeted drug delivery (BBB-penetrating molecules), gene therapies, monoclonal antibodies, and neuroprotective agents are shaping the next decade of CNS treatment. Pharmaceutical companies are shifting focus from symptomatic treatment to disease-modifying therapies, especially in neurodegenerative disorders.

Growing investments by biotech firms, expanding clinical pipelines, and favorable regulatory approvals from FDA and EMA are also catalyzing rapid market expansion.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/51211/central-nervou-s-system-therapeutics-market

Market Segmentation
By Disease Type
• Neurodegenerative Disorders
• Psychiatric Disorders
• Infectious CNS Diseases
• Pain Management
• Others (brain tumors, trauma-related disorders)
By Drug Class
• Analgesics
• Antidepressants
• Antipsychotics
• Antiepileptics
• Anesthetics
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Geography
• North America (largest share driven by R&D investments)
• Europe
• Asia Pacific (fastest-growing region)
• South America
• Middle East & Africa

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=51211

Recent Industry Developments
• 2024: Biogen and Eisai expanded Alzheimer's therapy collaborations for next-generation amyloid-targeting agents.
• 2023: FDA approved new treatments for rare epileptic disorders and resistant depression.
• 2023-2024: Roche, Novartis, and Teva increased investments in biologics and gene therapy platforms for neurodegenerative diseases.
• 2024: Multiple AI-driven neurology drug discovery programs launched by leading biotech firms.

Expert Quote
"The CNS therapeutics market is undergoing a transformation toward precision neurology, with targeted biologics and next-gen drug delivery technologies leading future growth," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy. "With increasing global neurological burden, companies investing in innovation will benefit from long-term expansion."

Market Drivers
• Rising prevalence of Alzheimer's, Parkinson's, and psychiatric disorders
• Advancements in BBB-penetrating formulations
• Growing demand for biologics & gene-based therapies
• Favorable regulatory approvals
• Increased healthcare spending worldwide

Forecast Outlook (2024-2034)
The market is expected to maintain steady growth as pharma innovators prioritize neurological R&D pipelines. Asia-Pacific will record the highest CAGR due to rapidly improving healthcare infrastructure and pharmaceutical expansion into emerging economies.

This report is also available in the following languages : Japanese (中枢神経系治療薬市場), Korean (중추신경계 치료제 시장), Chinese (美国中枢神经系统治疗市场), French (Marché américain des thérapies du système nerveux central), German (Markt für Therapeutika für das zentrale Nervensystem in den USA), and Italian (Mercato terapeutico del sistema nervoso centrale degli Stati Uniti), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/51211

Our More Reports:

Cryogenic Freezers Market
https://exactitudeconsultancy.com/reports/50194/cryogenic-freezers-market

Soft Skin Adhesives Market
https://exactitudeconsultancy.com/reports/50197/soft-skin-adhesives-market

Artificial Intelligence Ai In Medical Imaging Market
https://exactitudeconsultancy.com/reports/50199/artificial-intelligence-ai-in-medical-imaging-market

Laboratory Automation Market
https://exactitudeconsultancy.com/reports/50201/laboratory-automation-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Central Nervous System (CNS) Therapeutics Market to Reach USD 152.4 Billion by 2034 here

News-ID: 4274040 • Views:

More Releases from Exactitude Consultancy

Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitation and Infrastructure Projects
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250 Key Market Highlights • Increasing focus on road maintenance and resurfacing projects • Growing demand for efficient and precision milling
Credit Management Software Market Accelerates as Organizations Focus on Risk Mitigation and Cash Flow Optimization
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248 Key Market Highlights • Growing adoption of automated credit risk assessment tools • Increasing focus on working capital and cash flow management • Integration
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Operators Strengthen Network Security
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246 Key Market Highlights • Growing adoption of VoIP and
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Traction Amid Global Decarbonization Efforts
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244 Key Market Highlights • Rapid growth of

All 5 Releases


More Releases for CNS

CNS promotes craftsmanship of towel production in China
[https://youtu.be/oP-N73N0ey0] China News Service (CNS) issued a press release and a promo video here on Wednesday to promote the unique craftsmanship of towel production in Gaoyang [https://youtu.be/oP-N73N0ey0] County of Chinese northern Hebei Province. According to the CNS press release, Gaoyang is the largest hub of towel production in China, where one out of every three towels in the nation originates. More than 4200 textile enterprises are competing to flourish in this region,
Gene Therapy in CNS Disorder Market - Unlocking the Potential of Gene Therapy: T …
Newark, New Castle, USA: The "Gene Therapy in CNS Disorder Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Gene Therapy in CNS Disorder Market: https://www.growthplusreports.com/report/gene-therapy-in-cns-disorder-market/8886 This latest report
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system
Neuro Critical Care Market Insights in terms of volume and value 2018 to 2028(Mo …
Neuro critical care is an emerging field that combines the specialties that link neurology, neurosurgery, and critical care. Just as the field has evolved from primary focus on post-operative care to elective neurosurgical patients, the focus towards the resuscitation of neurological emergency cases such as traumatic brain injury or subarachnoid hemorrhage, which remain a clinical challenge. The neuro critical care market is strongly driven by the increasing focus, awareness, and
US CNS Disorders Drug Pipeline Insight 2014
The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of the
CNS Therapeutics Market Research Report 2016
“Global CNS Therapeutics Market Research Report 2016” Order This Report by calling BigMarketResearch.com at +1-971-202-1575 Notes: Production, means the output of CNS Therapeutics Revenue, means the sales value of CNS Therapeutics This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Pfizer, Inc. (USA) Johnson & Johnson (USA) Bristol-Myers Squibb